NGNE (STOCKS)
Neurogene, Inc. Common Stock
$23.950000
+1.770000 (+7.98%)
Prev close: $22.180000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Rachel L. McMinn
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $479.67M
- Employees
- 107
- P/E (TTM)
- -4.03
- P/B (TTM)
- 1.62
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-1.53 | $-1.45 | -0.0782 | -5.39% |
|
Mar 2026 (Q1)
|
$-1.39 | $-1.32 | -0.0678 | -5.13% |
|
Dec 2025 (Q4)
|
$-1.17 | $-1.21 | +0.0423 | +3.49% |
|
Sep 2025 (Q3)
|
$-0.99 | $-1.28 | +0.2850 | +22.35% |